Subscribe To
Eli lilly's head of diabetes and obesity unit to retire
Eli Lilly and Co said on Wednesday that the head of its diabetes and obesity division, Mike Mason, will...
October 4, 2023, 7:06 am
Structure therapeutics: tipping the scales in obesity management
Structure Therapeutics' oral small molecule GLP-1, GSBR-1290, has shown promising results in Phase 1b studies, surpassing competitor benchmarks for we...
October 3, 2023, 11:28 pm
Why shares of structure therapeutics are up monday
Analysts upgraded their price targets for Structure Therapeutics. The company's obesity therapy can be ...
October 2, 2023, 3:48 pm
Food additives market size will attain usd 170.49 billion by 2030 growing at 6.5% cagr – exclusive report by facts and factors
Massive demand for low-fat additives will open new growth avenues for the food additives market across the globe. Reportedly, low-fat additives compri...
September 30, 2023, 7:44 pm
Shares of biotech startup structure therapeutics surge more than 30% on promising obesity pill data
Structure's pill is part of the same class of drugs as Novo Nordisk's blockbuster diabetes drug Ozempic and weight loss counterpart Wegovy....
September 29, 2023, 12:02 pm
3 stocks to focus on as demand for obesity drugs booms
The market for obesity and weight management drugs is attracting a lot of interest lately in the United...
September 29, 2023, 11:17 am
Structure therapeutics surges on promising early stage obesity drug data
Shares of Structure Therapeutics soared 60% on Friday after the drug developer's oral obesity treatment...
September 29, 2023, 10:15 am
Ad spending for obesity, diabetes drugs is soaring this year, as drugmakers shell out nearly $500 million
The data demonstrates the rush by companies to capture new customers after months of hype around Novo Nordisk's Ozempic and Wegovy....
September 29, 2023, 9:00 am
3 biotech stocks to watch ahead of potential obesity drug approvals
The companies that already have obesity drugs can't keep up with the demand for their treatments, and t...
September 28, 2023, 8:45 am
Eli lilly set to dominate obesity drug market into the next decade, analysts say
Eli Lilly & Co. LLY, -3.42% is best positioned to dominate the fast-growing U.S. market for obesity dru...
September 22, 2023, 8:27 am
Vice health and wellness targets growing global obesity treatment market with ai app
Vice Health and Wellness (CSE:VICE) told investors it has made substantial progress with its newly-formed Vice Versa AI (artificial intelligence) app,...
September 19, 2023, 7:03 am
Eli lilly: a potential game changer for weight management and cardiovascular health
Eli Lilly's stock has performed well in the market, boosted by strong fundamental results and the success of Novo Nordisk's weight loss drug, Wegovy. ...
September 13, 2023, 11:19 pm
Altimmune (alt) rises 7% on completing dosing in obesity study
Altimmune (ALT) completes the dosing of all patients in the mid-stage obesity study of pemvidutide. The...
September 13, 2023, 9:01 am
Novo nordisk (nvo) reacted higher from support area
Novo Nordisk A/S (NVO), a healthcare company engages in the research, development, manufacture & marketing of the pharmaceutical products worldwide. I...
September 11, 2023, 5:45 pm
Weight loss drugs could prove potent for pph
Ozempic commercials are, at this point, ubiquitous and while that's an anecdotal example, it also represents confirmation that ...
September 11, 2023, 10:32 am
Big pharma's blockbuster obesity drug battle is just getting started, and it's headed for $100 billion
As Novo Nordisk and Eli Lilly duke it out in the weight-loss drug market with Ozempic, Wegovy and Mounjaro, drug company competitors plan to join the ...
September 9, 2023, 9:19 am
The economic cost of obesity is expected to soar to $4 trillion by 2035. weight loss drugs like ozempic could change that, goldman sachs says.
The rise in obesity is having a massive impact on the global economy, according to Goldman Sachs. The b...
September 8, 2023, 1:44 pm
Mizuho's jared holz reacts to jpmorgan's huge obesity drug call
Jared Holz, Mizuho, joins 'Fast Money' to talk JPMorgans $100 billion call on weight loss drugs....
September 7, 2023, 6:58 pm
Weight-loss drug market can hit $100 billion, j.p. morgan says.
Eli Lilly and Denmark's Novo Nordisk are expected to roughly split the market for weight-loss drugs, both as diabetes and ...
September 7, 2023, 11:39 am
Wegovy drugmaker novo nordisk to make $70bn a year from weight-loss alone, as analysts await full select trial data
As researchers work to test whether Novo Nordisk (NYSE:NVO)'s fat-busting drug Wegovy can also be used as a treatment for dementia and alcohol addicti...
September 7, 2023, 11:09 am
